Advertisement
Advertisement
ABT
Abbott Laboratories
109.26
USDSponsored
+0.77
+0.71%
Mar 19, 09:52 UTC -4
Open
ABT Earnings Reports
Positive Surprise Ratio
ABT beat 29 of 40 last estimates.
73%
Next Report
Date of Next Report
Apr 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$11.10B
/$1.16
Implied change from Q4 25 (Revenue/ EPS)
-3.13%
/-22.67%
Implied change from Q1 25 (Revenue/ EPS)
+7.17%
/+6.42%
Abbott Laboratories earnings per share and revenue
On Jan 22, 2026, ABT reported earnings of 1.50 USD per share (EPS) for Q4 25, missing the estimate of 1.51 USD, resulting in a -0.75% surprise. Revenue reached 11.46 billion, compared to an expected 11.92 billion, with a -3.88% difference. The market reacted with a -10.04% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 24 analysts forecast an EPS of 1.16 USD, with revenue projected to reach 11.10 billion USD, implying an decrease of -22.67% EPS, and decrease of -3.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Abbott Laboratories's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Abbott Laboratories reported EPS of $1.50, missing estimates by -0.75%, and revenue of $11.46B, -3.88% below expectations.
How did the market react to Abbott Laboratories's Q4 2025 earnings?
The stock price moved down -10.04%, changed from $120.73 before the earnings release to $108.61 the day after.
When is Abbott Laboratories expected to report next?
The next earning report is scheduled for Apr 14, 2026.
What are the forecasts for Abbott Laboratories's next earnings report?
Based on 24
analysts, Abbott Laboratories is expected to report EPS of $1.16 and revenue of $11.10B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement